Fibromyalgia Treatment: Medications, Lifestyle Changes, and Emerging Therapies That Actually Help

The most effective fibromyalgia treatment is a combined plan of graded exercise, sleep repair, psychological therapy and, when needed, medication, because no single drug or therapy reliably controls the condition on its own. Exercise is the only therapy that the European Alliance of Associations for Rheumatology (EULAR) rated "strong for" in its 2017 recommendations, and the FDA has now approved four drugs for fibromyalgia: pregabalin (Lyrica), duloxetine (Cymbalta), milnacipran (Savella) and, since August 2025, sublingual cyclobenzaprine (Tonmya).

Why Fibromyalgia Is Hard to Treat

Fibromyalgia is a central sensitization disorder. The brain and spinal cord amplify pain signals, turning inputs that shouldn’t hurt into inputs that do. This isn’t a peripheral tissue problem you can cut out or inject away. It’s a nervous system that has turned up the volume on pain processing and won’t turn it back down [1].

Clinicians also call this nociplastic pain: pain driven by altered pain processing rather than by tissue damage or nerve injury. Daniel Clauw, writing in JAMA in 2014, describes fibromyalgia as the prototypical central pain condition, which is why it so often travels with chronic fatigue syndrome (ME/CFS), irritable bowel syndrome, migraine and TMJ disorder [1].

This matters for treatment because it explains why approaches targeting a single pathway, whether that’s one medication or one lifestyle change, rarely produce satisfying results. The nervous system recalibration that fibromyalgia requires demands multiple inputs working together: pharmacology to modulate neurotransmitters, movement to retrain pain pathways, sleep to allow nervous system repair, and psychological strategies to interrupt the stress-pain cycle.

The patients who do best are the ones who build a multimodal plan and stick with it long enough to see cumulative effects. Symptom improvement often takes 8 to 12 weeks of consistent effort across multiple domains, which is longer than most people expect. For the background on what sets the process off, see what triggers central sensitization.

What Is the Best Treatment for Fibromyalgia?

The best-supported fibromyalgia treatment is a graded exercise program, started with patient education and combined with sleep and psychological care, with medication added for severe pain or poor sleep. That sequence comes straight from the EULAR revised recommendations, led by Gary Macfarlane and published in the Annals of the Rheumatic Diseases in 2017 [15].

EULAR's panel reviewed 107 systematic reviews and meta-analyses. Exercise was the only therapy rated "strong for." Most other options, including the FDA-approved drugs, CBT, acupuncture, hydrotherapy and meditative movement such as tai chi, earned a "weak for" rating, meaning they help some people modestly and should be matched to the individual [15].

The table below summarizes the main options covered in the sections that follow, using the doses and findings already cited in each section.

FDA-Approved Medications

Four medications carry FDA approval specifically for fibromyalgia. They work through different mechanisms and have different side effect profiles, so the choice depends on which symptoms are most prominent. Pregabalin came first in 2007, duloxetine and milnacipran followed, and sublingual cyclobenzaprine was added in August 2025 [16].

Duloxetine (Cymbalta)

Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that increases both serotonin and norepinephrine in the descending pain inhibitory pathways. The typical dose for fibromyalgia is 60 mg daily. Clinical trials showed that duloxetine reduced pain by at least 30% in about 40-50% of patients compared to roughly 30% on placebo [2].

Common side effects include nausea (usually transient in the first 1-2 weeks), dry mouth, constipation, drowsiness, and decreased appetite. Duloxetine is a reasonable first choice for patients who have co-existing depression or anxiety, since it treats both simultaneously. Starting at 30 mg for the first week and then increasing to 60 mg helps reduce the initial nausea.

Pregabalin (Lyrica)

Pregabalin is an alpha-2-delta ligand that reduces the release of excitatory neurotransmitters including glutamate, norepinephrine, and substance P. It was the first medication approved for fibromyalgia. The therapeutic dose range is 300-450 mg daily, divided into two or three doses [3].

Pregabalin is particularly useful when sleep disruption and anxiety are prominent features. It tends to improve sleep quality more than duloxetine. The main drawbacks are weight gain, peripheral edema, dizziness, and cognitive blunting (“Lyrica fog”). Starting low (75 mg at bedtime) and titrating slowly over several weeks reduces the incidence of side effects.

Milnacipran (Savella)

Milnacipran is another SNRI, but it has a stronger norepinephrine effect relative to serotonin compared to duloxetine. The target dose is 50 mg twice daily. It tends to be less sedating than the other options and may be a better fit for patients whose primary complaint is fatigue rather than sleep disruption [4].

Side effects are similar to duloxetine: nausea, headache, constipation, and increased heart rate. Milnacipran is less widely prescribed than duloxetine, partly because it’s less effective for co-existing depression at fibromyalgia doses, and partly because prescriber familiarity is lower.

Sublingual Cyclobenzaprine (Tonmya)

Sublingual cyclobenzaprine is a low-dose, under-the-tongue form of the muscle relaxant cyclobenzaprine, approved by the FDA on August 15, 2025 as a once-daily bedtime treatment for fibromyalgia in adults. It was studied as TNX-102 SL, and its maker describes it as the first new fibromyalgia drug approved in more than 15 years.

According to the FDA prescribing information (2025), the starting dose is 2.8 mg at bedtime for days 1 to 14, then 5.6 mg at bedtime, which is also the maximum dose. Approval rested on placebo-controlled trials that measured daily pain scores, and the drug is thought to act largely by improving the quality of sleep. Expect mouth numbness or tingling where the tablet dissolves, plus drowsiness, and ask about interactions if you already take an antidepressant [16].

How to Think About These Medications

None of these drugs are home runs. A 30% pain reduction in 40-50% of patients is a modest effect, and it’s roughly what the clinical trials show for the three older drugs, while the newer sublingual cyclobenzaprine trials also reported modest average gains. Many patients try one or two and stop because of side effects or insufficient benefit. That’s a reasonable response, but it shouldn’t mean abandoning pharmacotherapy entirely. These medications work best as one component of a broader plan, and they may need 6-8 weeks at therapeutic doses before you can fairly evaluate their effect.

What About Opioids and Other Pain Relievers?

Strong opioids are a poor fit for fibromyalgia, and the EULAR panel recommends against them [15]. Central sensitization does not respond the way injury pain does, and long-term opioid use can worsen pain sensitivity. Over-the-counter NSAIDs such as ibuprofen do little for the core pain, though they can help a flare from an overlapping joint problem. For practical alternatives, see non-opioid strategies for long-term pain.

Low-Dose Naltrexone (LDN)

LDN has become one of the most talked-about off-label treatments for fibromyalgia, and the early evidence is encouraging. Naltrexone at standard doses (50 mg) is an opioid antagonist used for addiction. At low doses (1.5-4.5 mg), it appears to work through a different mechanism: modulating microglial activation in the central nervous system and reducing neuroinflammation [5].

A Stanford crossover trial led by Jarred Younger (2013) found that LDN at 4.5 mg daily reduced baseline fibromyalgia pain by 28.8%, compared with an 18.0% reduction on placebo, in 31 women. Responder analysis showed that 32% of participants met the response criteria on LDN (a significant drop in pain plus a drop in fatigue or sleep problems), compared with 11% on placebo. Side effects were minimal, with vivid dreams being the most commonly reported [6].

A 2018 review by Patten and colleagues in Pharmacotherapy looked at LDN across fibromyalgia, multiple sclerosis, Crohn’s disease and other chronic pain disorders. It concluded that LDN is well tolerated and shows early signs of benefit, and that larger controlled trials are still needed [7]. Patients with overlapping inflammatory or immune conditions are the group integrative clinicians most often describe as good responders, though that pattern has not been tested in a large trial.

LDN is not FDA-approved for fibromyalgia. It requires a prescription from a willing provider and is typically filled by compounding pharmacies. Costs range from $30-60 per month out of pocket. The usual approach is to start at 1.5 mg at bedtime and increase by 0.5-1.5 mg every 1-2 weeks up to 4.5 mg. Sleep disruption or vivid dreams in the first week usually resolve on their own.

Who Should Not Take LDN?

LDN blocks opioid receptors, so it cannot be combined with opioid pain medication, including tramadol, without risk of withdrawal or losing pain control. Rheumatologists, integrative physicians and some primary care doctors prescribe it. Dosing, tapering and drug interactions are covered in more depth in LDN for fibromyalgia and what to avoid while taking LDN.

Exercise: The Treatment Nobody Wants to Hear About

If there is one intervention with the most consistent evidence across dozens of systematic reviews and meta-analyses, it’s exercise. A 2017 Cochrane review led by Julia Bidonde concluded that moderate-intensity aerobic exercise probably improves quality of life and physical function and may reduce pain in fibromyalgia, based on low to moderate certainty evidence [8]. EULAR made exercise its only "strong for" recommendation the same year, ahead of every medication [15].

That said, telling someone with widespread pain and crushing fatigue to “just exercise” is not helpful advice. The type, intensity, and progression matter enormously.

What Works

• Aquatic exercise: Water-based programs consistently show the highest adherence and strongest effect sizes. The buoyancy reduces joint loading, and warm water has an independent analgesic effect. Two to three sessions per week of 30-45 minutes is the most studied protocol.
• Walking programs: Starting with 10-15 minutes at a comfortable pace and increasing by no more than 10% per week. This is often the most practical starting point for deconditioned patients.
• Resistance training: Light-to-moderate resistance training 2-3 times per week improves pain, physical function, and muscle strength. Bodyweight exercises or resistance bands are reasonable starting points [9].
• Yoga and tai chi: Randomized trials show these are effective for fibromyalgia pain and function, with additional benefits for sleep and psychological well-being. A 2018 BMJ trial found that tai chi was at least as effective as aerobic exercise and possibly superior for some outcomes [10].

How to Start Without Flaring

The biggest mistake is doing too much too soon and triggering a multi-day pain flare that destroys motivation. Start at 50% of what you think you can do. If you think you can walk for 20 minutes, start with 10. Increase slowly. If a new level of activity causes a flare lasting more than 24 hours, back off to the previous level for another week before trying again.

Consistency matters more than intensity. Three 15-minute sessions per week sustained over 3 months will produce better outcomes than one aggressive 45-minute session followed by a week on the couch.

Who Can Help You Build an Exercise Plan?

A physical therapist or a physiatrist (a physical medicine and rehabilitation physician) can set a starting level and a progression that respects post-exertional flares. Many hospital systems run warm-water pool programs designed for arthritis and fibromyalgia. When a flare does happen, the recovery steps in managing a fibromyalgia flare-up help you return to the plan rather than abandon it.

Sleep Optimization

Disrupted sleep isn’t just a symptom of fibromyalgia. It’s a driver of the disease. Research shows that sleep deprivation alone, even in healthy volunteers, can produce fibromyalgia-like widespread pain and tenderness within days. Alpha-wave intrusion during deep sleep, a pattern where the brain partially wakes during restorative sleep stages, is found in up to 70% of fibromyalgia patients [11].

Pharmacological Sleep Support

• Low-dose amitriptyline: 10-25 mg at bedtime. Improves sleep quality and has modest analgesic effects. Well-studied in fibromyalgia. Main side effects: morning grogginess, dry mouth, weight gain.
• Trazodone: 25-100 mg at bedtime. Less anticholinergic than amitriptyline. Good option for patients who need sleep help without significant pain relief from the sleep medication itself.
• Gabapentin: 100-600 mg at bedtime. Similar mechanism to pregabalin but available as a generic at lower cost. Useful when sleep and neuropathic pain overlap.
• Melatonin: 3-5 mg at bedtime. Modest but consistent evidence for sleep onset improvement. Extended-release formulations may help with sleep maintenance.

Sublingual cyclobenzaprine, covered in the medication section above, is also taken at bedtime and is thought to work partly by deepening sleep, so clinicians are cautious about combining it with amitriptyline, which is chemically similar.

Non-Pharmacological Sleep Strategies

Cognitive behavioral therapy for insomnia (CBT-I) is the gold-standard treatment for chronic insomnia and has been specifically studied in fibromyalgia populations. A randomized trial demonstrated that CBT-I not only improved sleep but also reduced pain intensity in fibromyalgia patients [12]. It addresses the hyperarousal and maladaptive sleep habits that perpetuate insomnia, and its effects are more durable than sleep medications.

Temperature regulation, light exposure management (bright light in the morning, blue-light blocking in the evening), and consistent sleep-wake timing are all worth implementing, though they’re rarely sufficient on their own for fibromyalgia-related sleep disruption.

Should You Be Tested for Sleep Apnea?

Loud snoring, gasping at night or unrefreshing sleep despite enough hours are reasons to ask for a sleep study. Obstructive sleep apnea fragments deep sleep in the same way fibromyalgia does, and treating it removes one driver of pain amplification. A sleep medicine physician can order home or lab testing, and the options are outlined in the sleep apnea treatment guide.

Cognitive Behavioral Therapy (CBT) for Pain

CBT for chronic pain is not about telling patients their pain is psychological. It’s about addressing the cognitive and behavioral patterns that amplify pain perception and reduce functional capacity. Pain catastrophizing, the tendency to ruminate on pain, magnify its threat, and feel helpless in the face of it, is one of the strongest predictors of disability in fibromyalgia. CBT directly targets this pattern [13].

A meta-analysis found that CBT produced small-to-moderate improvements in pain, disability, and mood in fibromyalgia patients, with effects that persisted at 6-month follow-up. The strongest effects were on catastrophizing and self-efficacy rather than on pain intensity itself, suggesting that CBT changes the relationship with pain more than the pain signal itself [13].

Acceptance and Commitment Therapy (ACT), a related approach, has also shown promise in fibromyalgia. ACT focuses on psychological flexibility: the ability to pursue valued activities even in the presence of pain, rather than waiting for pain to resolve before re-engaging with life.

Psychologists who specialize in pain deliver CBT and ACT, often within a hospital pain program, and many now offer sessions by video. Biofeedback, which teaches control of muscle tension, breathing and heart rate variability, is a related skills-based option described in biofeedback for chronic pain.

Emerging and Regenerative Approaches

Several newer therapies are gaining traction in integrative fibromyalgia care. Most are offered as cash pay, are used off label for fibromyalgia, and rest on smaller studies than the treatments above, so they make the most sense as additions to a plan that already covers movement, sleep and mood.

IV Nutrient Therapy

Intravenous magnesium, B vitamins, and vitamin C (variations of the Myers’ cocktail) are commonly offered by integrative practitioners. The rationale is that fibromyalgia patients often have functional nutrient deficiencies related to mitochondrial dysfunction and oxidative stress. Small studies have shown short-term improvement in pain and fatigue, but large controlled trials are lacking. IV NAD+ is also being explored for its potential to support mitochondrial function, though evidence specific to fibromyalgia remains preliminary.

Oral magnesium is a cheaper first step for many people, and the forms of magnesium differ in absorption and gut tolerance. The IV therapy treatment guide explains what an infusion visit involves, and the national list of IV therapy clinics shows who offers it near you.

Peptide Therapy

BPC-157, a synthetic peptide derived from a protein found in gastric juice, has demonstrated anti-inflammatory and neuroprotective effects in animal studies. Some integrative practitioners are using it off-label for fibromyalgia-related pain and gut symptoms. Thymosin alpha-1 is another peptide being explored for its immune-modulating properties. Clinical data in fibromyalgia populations is still very early-stage.

The FDA has listed BPC-157 among bulk drug substances that raise significant safety concerns for compounding, which limits legitimate supply. The peptide therapy overview covers sourcing and oversight in more detail.

Transcranial Magnetic Stimulation (TMS)

Repetitive TMS targeting the motor cortex or dorsolateral prefrontal cortex has shown analgesic effects in fibromyalgia in multiple randomized trials. A meta-analysis found that TMS produced significant reductions in pain intensity, with effects lasting several weeks after a treatment course [14]. This makes sense given the central sensitization model: directly modulating brain activity in regions involved in pain processing addresses the problem at its source.

TMS is FDA cleared for depression, migraine and obsessive-compulsive disorder, but its use for fibromyalgia pain is off label, so insurers rarely cover it unless depression is also being treated. The transcranial magnetic stimulation guide explains what a treatment course involves, and you can compare TMS providers listed in the directory.

Hyperbaric Oxygen Therapy (HBOT)

Hyperbaric oxygen therapy delivers 100% oxygen inside a pressurized chamber. In a 2015 crossover trial in PLoS One, Shai Efrati and colleagues treated 60 women with fibromyalgia and reported improvement in pain, function and quality of life, alongside changes on brain SPECT imaging [17]. It was a single small study without a sham control, and fibromyalgia is not on the FDA or Undersea and Hyperbaric Medical Society (UHMS) list of approved HBOT indications, so it is cash pay. Read the HBOT treatment guide before you browse hyperbaric clinics in the directory.

Ketamine Infusions

Ketamine is an NMDA receptor blocker that dampens central sensitization in the short term. Small fibromyalgia studies of IV ketamine have shown pain relief that is usually short-lived, and controlled evidence for repeated infusions is thin. It is most often considered when severe depression travels with the pain. The ketamine therapy guide covers screening and monitoring.

Stem Cell Therapy

Stem cell therapy has no completed large controlled trials in fibromyalgia, and no stem cell product holds FDA approval for it. Because fibromyalgia is a disorder of pain processing rather than tissue damage, the rationale is weaker here than for joint conditions. Read what the FDA has and has not approved before paying for an injection marketed for widespread pain.

How Long Does Fibromyalgia Treatment Take to Work?

Most fibromyalgia treatments take 6 to 12 weeks to show a fair result, and a full multimodal plan usually needs 3 months or more. The timelines below are the ones already cited in each section above.

Changing one thing at a time makes it possible to tell what helped. If two treatments start in the same week and you improve, neither can be credited, and if you flare, neither can be blamed.

Building a Multimodal Treatment Plan

The most effective approach to fibromyalgia treatment stacks multiple interventions that target different aspects of the disease:

• Medication: Choose based on symptom profile. Pain-predominant? Start with duloxetine or pregabalin. Fatigue-predominant? Consider milnacipran or LDN. Sleep-predominant? Low-dose amitriptyline or gabapentin at bedtime.
• Movement: Start with the lowest-barrier form of exercise you’ll actually do consistently. Aquatic therapy, walking, or tai chi are all evidence-based starting points. Build gradually over 3+ months.
• Sleep: Address with medication if needed, but pursue CBT-I as the long-term solution. Treat any underlying sleep disorders (sleep apnea is underdiagnosed in fibromyalgia).
• Psychology: CBT for pain management, not as a substitute for medical treatment. Focus on reducing catastrophizing and building self-efficacy.
• Nutrition: An anti-inflammatory dietary pattern (Mediterranean-style) is reasonable. Identify and eliminate any food sensitivities. Optimize vitamin D, magnesium, and omega-3 intake.

Give each new intervention at least 8-12 weeks before evaluating. Track symptoms with a daily log so you can see gradual trends rather than relying on how you feel on any given day. Fibromyalgia improvement is often slow and nonlinear. Patients frequently report that they didn’t realize how much better they’d gotten until they looked back at their symptom logs from months earlier.

A Step-by-Step Starting Order

1. Confirm the diagnosis and rule out look-alikes such as hypothyroidism, lupus and inflammatory arthritis with your primary care doctor or a rheumatologist.
2. Learn how central sensitization works: EULAR lists patient education as the first step of care [15].
3. Start a graded exercise program at half of what you think you can do.
4. Fix sleep: screen for sleep apnea and begin CBT-I.
5. Add a medication matched to your main symptom if pain or sleep stays severe.
6. Add CBT or ACT if catastrophizing, low mood or avoidance is limiting you.
7. Consider off-label or emerging options such as LDN or TMS only after the core plan is running.

Who Treats Fibromyalgia and How to Find Care

Fibromyalgia is usually diagnosed and managed by a primary care physician or a rheumatologist, using the American College of Rheumatology (ACR) criteria for widespread pain and symptom severity. Pain medicine physicians, physiatrists, physical therapists, pain psychologists and sleep medicine physicians each handle a piece of the plan. Integrative and functional medicine clinicians are the group most likely to offer LDN, IV nutrient therapy, peptides or HBOT.

The fibromyalgia treatment guide summarizes these options for the directory, and the fibromyalgia condition page links the treatments clinics list for it. Regenerated.com is free for patients. Listing order is not paid ranking, Featured slots are labeled and capped, and Verified means a clinic completed credential checks, not that it spent more. Inclusion in the directory is not an endorsement, and the guide to Featured, Verified and organic listings explains each label.

Before booking an integrative clinic, ask which conditions it treats most, who supervises infusions or procedures, how it measures progress, and whether it will coordinate with your rheumatologist. A clinic that offers a single therapy as the whole answer to fibromyalgia is out of step with the evidence summarized above.

Frequently asked questions

What is the most effective treatment for fibromyalgia?

Graded exercise is the most effective single treatment for fibromyalgia, and it was the only therapy EULAR rated "strong for" in 2017. The best results come from combining it with sleep repair, CBT and, when pain or sleep stays severe, a medication such as duloxetine, pregabalin, milnacipran or sublingual cyclobenzaprine. No single drug works for everyone, so most people try more than one option and judge each over 8 to 12 weeks.

What is the new FDA-approved drug for fibromyalgia?

The newest FDA-approved fibromyalgia drug is Tonmya, a sublingual form of cyclobenzaprine approved on August 15, 2025. It dissolves under the tongue at bedtime, starting at 2.8 mg for two weeks and then 5.6 mg nightly, according to the FDA label. It joins pregabalin, duloxetine and milnacipran, making four approved options. Trial benefits were modest, and common side effects include mouth numbness and drowsiness.

Does low-dose naltrexone work for fibromyalgia?

Low-dose naltrexone helps some people with fibromyalgia, but the evidence comes from small trials. In a 2013 Stanford crossover study of 31 women, 4.5 mg nightly reduced pain by 28.8% versus 18.0% on placebo. LDN is prescribed off label, filled by compounding pharmacies, started at 1.5 mg and raised slowly, and it cannot be combined with opioid pain medication.

Can fibromyalgia go away with treatment?

Fibromyalgia is usually a long-term condition, but many people reach long stretches of low symptoms with a consistent plan. Improvement tends to be gradual and uneven, which is why a daily symptom log helps you see progress over months. Treatment aims to lower pain sensitivity, restore sleep and rebuild function rather than to make the diagnosis disappear, and flares often become shorter and less frequent.

Does insurance cover fibromyalgia treatment?

Insurance generally covers fibromyalgia visits, FDA-approved medications, physical therapy and psychological therapy, subject to your plan's rules and prior authorization. Off-label options such as low-dose naltrexone, IV nutrient therapy, peptides, HBOT and TMS for pain are usually paid out of pocket. Ask the clinic for a written estimate and check whether a diagnosis such as depression changes coverage for TMS before starting.

Which doctor should I see for fibromyalgia treatment?

A primary care physician or a rheumatologist usually diagnoses fibromyalgia and coordinates treatment. Pain medicine physicians, physiatrists, physical therapists, pain psychologists and sleep specialists each handle part of the plan. Integrative clinicians are the main source of off-label options such as LDN, IV therapy and HBOT. Choose a clinician who will work alongside the others rather than offering a single therapy as the whole answer.

Related Reading

• Fibromyalgia: Understanding Central Sensitization and Your Treatment Options (Pillar)
• Fibromyalgia Causes: What Triggers Central Sensitization?
• Chronic Fatigue Syndrome Treatment: What Helps and What Doesn’t
• Chronic Pain Management Without Opioids
• TMS Therapy Cost: What to Expect and How to Get Coverage
• Types of Magnesium: Which Form Is Right for You?
• Fibromyalgia Diet: What to Eat and What to Limit
• Fibromyalgia Brain Fog: Causes and Coping Strategies

Sources

1. Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547-1555. doi:10.1001/jama.2014.3266 ↩
2. Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50(9):2974-2984. doi:10.1002/art.20485 ↩
3. Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52(4):1264-1273. doi:10.1002/art.20983 ↩
4. Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther. 2008;30(11):1988-2004. doi:10.1016/j.clinthera.2008.11.009 ↩
5. Younger J, Mackey S. Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med. 2009;10(4):663-672. doi:10.1111/j.1526-4637.2009.00613.x ↩
6. Younger J, Noor N, McCue R, Mackey S. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum. 2013;65(2):529-538. doi:10.1002/art.37734 ↩
7. Patten DK, Schultz BG, Berlau DJ. The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, Crohn’s disease, and other chronic pain disorders. Pharmacotherapy. 2018;38(3):382-389. doi:10.1002/phar.2086 ↩
8. Bidonde J, Busch AJ, Schachter CL, et al. Aerobic exercise training for adults with fibromyalgia. Cochrane Database Syst Rev. 2017;6(6):CD012700. doi:10.1002/14651858.CD012700 ↩
9. Busch AJ, Webber SC, Richards RS, et al. Resistance exercise training for fibromyalgia. Cochrane Database Syst Rev. 2013;(12):CD010884. doi:10.1002/14651858.CD010884 ↩
10. Wang C, Schmid CH, Fielding RA, et al. Effect of tai chi versus aerobic exercise for fibromyalgia: comparative effectiveness randomized controlled trial. BMJ. 2018;360:k851. doi:10.1136/bmj.k851 ↩
11. Moldofsky H. The significance of the sleeping-waking brain for the understanding of widespread musculoskeletal pain and fatigue in fibromyalgia syndrome and allied syndromes. Joint Bone Spine. 2008;75(4):397-402. doi:10.1016/j.jbspin.2008.01.021 ↩
12. Martinez MP, Miro E, Sanchez AI, et al. Cognitive-behavioral therapy for insomnia and sleep hygiene in fibromyalgia: a randomized controlled trial. J Behav Med. 2014;37(4):683-697. doi:10.1007/s10865-013-9520-y ↩
13. Bernardy K, Klose P, Busch AJ, Choy EH, Hauser W. Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev. 2013;(9):CD009796. doi:10.1002/14651858.CD009796.pub2 ↩
14. Saltychev M, Laimi K. Effectiveness of repetitive transcranial magnetic stimulation in patients with fibromyalgia: a meta-analysis. Int J Rehabil Res. 2017;40(1):11-18. doi:10.1097/MRR.0000000000000207 ↩
15. Macfarlane GJ, Kronisch C, Dean LE, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318-328. doi:10.1136/annrheumdis-2016-209724. PubMed ↩
16. US Food and Drug Administration. Tonmya (cyclobenzaprine hydrochloride sublingual tablets) prescribing information, NDA 219428. August 2025. FDA label ↩
17. Efrati S, Golan H, Bechor Y, et al. Hyperbaric oxygen therapy can diminish fibromyalgia syndrome: prospective clinical trial. PLoS One. 2015;10(5):e0127012. doi:10.1371/journal.pone.0127012. PubMed ↩